This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant risk factors for arrhythmias post-HT. On a median follow-up of 35.07
Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. In adults, arrhythmias such as atrial fibrillation and flutter are the most frequent acute cardiovascular complication.
The most common MAE was arrhythmia, representing 46% of MAE, followed by cardiac arrest and bleeding each 20%. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001.
months, no deaths, left ventricular failure, malignant arrhythmias, tumor recurrence were observed in the other patients.Conclusion:Our modified ventricular reconstruction procedure has proven successful. 2 steps were performed during modified ventricular reconstruction procedure. During a median follow-up period of 17.4
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. The transplant-free survival rates at 3, 5, and 8 years after CRT implantation were 85%, 79%, and 73%.CONCLUSIONS:In Although cardiac resynchronization therapy (CRT) is an established treatment option, the effect of CRT in this population is still not well defined.
Acute coronary syndrome in a pediatric patient? An ECG was perfomed on arrival to our ED: NSR with ST elevation II,III, aVF with reciprocal depression in aVL Would you refer this pediatric patient for emergent PCI? World J Pediatr. The workup at the transferring hospital yielded elevated troponin I at 18.1 Epub 2021 May 20.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content